Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.88 is 50% below its 5-year average of 3.75, near the low end of its 5-year range (1.67–11.65).
As of the fiscal period ended Tuesday, June 30, 2026. 4.32% below its 12-month average of 1.97.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.88.
CURRENT RATIO
1.88
CURRENT RATIO AVG TTM
1.97
CURRENT RATIO AVG 3Y
3.08
CURRENT RATIO AVG 5Y
3.75
CURRENT RATIO AVG 10Y
3.76
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-4.32%
CURRENT VS 3Y AVG
-38.97%
CURRENT VS 5Y AVG
-49.92%
CURRENT VS 10Y AVG
-49.98%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
-49.99%
vs the sector median at left
Market Cap
$153.58M
Current Ratio
0.45
TTM Avg
0.24
3Y Avg
0.20
5Y Avg
0.38
Market Cap
$151.01M
Current Ratio
5.55
TTM Avg
4.34
3Y Avg
4.83
5Y Avg
5.46
Market Cap
$149.36M
Current Ratio
9.71
TTM Avg
4.67
3Y Avg
6.04
5Y Avg
19.74
Market Cap
$148.73M
Current Ratio
0.82
TTM Avg
5.49
3Y Avg
4.19
5Y Avg
4.20
Market Cap
$148.64M
Current Ratio
7.51
TTM Avg
6.60
3Y Avg
4.97
5Y Avg
4.99
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Neuronetics, Inc. (STIM) | $153.79M | 1.88 | 1.97 | 3.08 | 3.75 |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $153.58M | 0.45 | 0.24 | 0.20 | 0.38 |
| Veraxa Biotech Holding AG (VRXA)vs › | $152.72M | N/A | N/A | N/A | N/A |
| Inogen, Inc. (INGN)vs › | $156.22M | 2.74 | 2.77 | 3.26 | 3.97 |
| Cardiol Therapeutics Inc. (CRDL)vs › | $151.01M | 5.55 | 4.34 | 4.83 | 5.46 |
| ALX Oncology Holdings Inc. (ALXO)vs › | $149.36M | 9.71 | 4.67 | 6.04 | 19.74 |
| Korsana Biosciences, Inc. (KRSA)vs › | $148.73M | 0.82 | 5.49 | 4.19 | 4.20 |
| Voyager Therapeutics, Inc. (VYGR)vs › | $148.64M | 7.51 | 6.60 | 4.97 | 4.99 |
| Coherus Oncology, Inc. (CHRS)vs › | $159.14M | 1.77 | 1.33 | 1.71 | 2.63 |
| LifeMD, Inc. (LFMDP)vs › | $159.22M | 0.90 | 1.03 | 0.91 | 1.08 |
Current Ratio
1.88
Quick Ratio
1.69
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.88 |
| 2026-03-31 | 1.67 |
| 2025-12-31 | 2.02 |
| 2025-09-30 | 2.24 |
| 2025-06-30 | 2.02 |
| 2025-03-31 | 2.44 |
| 2024-12-31 | 1.86 |
| 2024-09-30 | 3.16 |
| 2024-06-30 | 2.58 |
| 2024-03-31 | 5.65 |
| 2023-12-31 | 4.73 |
| 2023-09-30 | 4.63 |
| 2023-06-30 | 5.17 |
| 2023-03-31 | 5.36 |
| 2022-12-31 | 2.98 |
| 2022-09-30 | 4.02 |
| 2022-06-30 | 5.02 |
| 2022-03-31 | 7.82 |
| 2021-12-31 | 7.34 |
| 2021-09-30 | 2.50 |
| 2021-06-30 | 11.65 |
| 2021-03-31 | 12.74 |
| 2020-12-31 | 4.75 |
| 2020-09-30 | 1.42 |
| 2020-06-30 | 1.48 |
| 2020-03-31 | 6.17 |
| 2019-12-31 | 3.19 |
| 2019-09-30 | 4.36 |
| 2019-06-30 | 6.10 |
| 2019-03-31 | 8.94 |
| 2018-12-31 | 8.44 |
| 2018-09-30 | 7.63 |
| 2018-06-30 | 1.75 |
| 2018-03-31 | 2.90 |
| 2017-12-31 | 3.09 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
